PTGX Intrinsic Valuation and Fundamental Analysis - Protagonist Therapeutics Inc

	Protagonist Therapeutics Inc NASDAQ:PTGX	US
K	Kadant Inc F:KDA	US

Intrinsic Value

The intrinsic value for Protagonist Therapeutics Inc (PTGX) under the Base Case is 34.81 USD. Compared with the current market price of 131.42 USD, the stock appears Overvalued by 74% .

DCF Value

$54.3

Multiples-Based Value

$15.32

DCF Value

$54.3

Multiples-Based Value

$15.32

Both DCF and multiples point to overvaluation.

Why combine DCF with multiples? What is Intrinsic Value?

PTGX Intrinsic Value

Overvaluation 74%

Intrinsic Value

Price $131.42

Bear Case

Base Case

Bull Case

Track Buy Zone

20% below Intrinsic Value $27.85

Get notified when the price drops into your buy zone

Current Price $131.42

Intrinsic Value $34.81

Margin of Safety 20% $27.85

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Protagonist Therapeutics Inc.

Explain Valuation